{"id":1583,"date":"2020-12-12T09:16:53","date_gmt":"2020-12-12T08:16:53","guid":{"rendered":"http:\/\/invivo.partners\/?post_type=portoflio_invivo&#038;p=1583"},"modified":"2023-12-12T10:53:49","modified_gmt":"2023-12-12T09:53:49","slug":"telomere-therapeutics","status":"publish","type":"portoflio_invivo","link":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/","title":{"rendered":"Telomere Therapeutics"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\">Telomere Therapeutics \u00e9s una empresa <em>spin-off <\/em>del <strong>Centro Nacional de Investigaciones Oncol\u00f3gicas<\/strong> (CNIO) i de la <strong>Universitat Aut\u00f2noma de Barcelona<\/strong> (UAB). Telomere \u00e9s una empresa de ter\u00e0pia g\u00e8nica que desenvolupa tractaments modificadors de malalties per a necessitats m\u00e8diques no cobertes, sent pionera en la \u00abreparaci\u00f3 dels tel\u00f2mers\u00bb per tractar la fibrosi i altres s\u00edndromes de disfunci\u00f3 dels tel\u00f2mers per als quals no existeix tractament curatiu. El programa principal es centra en una ter\u00e0pia g\u00e8nica <em>in vivo<\/em> basada en l&#8217;expressi\u00f3 de el gen de la telomerasa (<strong>TERT<\/strong>) mitjan\u00e7ant un vector AAV per a la <strong>fibrosi pulmonar idiop\u00e0tica.<\/strong><\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>COO: Michael Tadros<\/li>\r\n<li>Fundadores: Dra. Maria Blasco i Dra. F\u00e0tima Bosch<\/li>\r\n<li>Ubicaci\u00f3: Barcelona<\/li>\r\n<li>P\u00e0gina web: <a href=\"https:\/\/telomere-tx.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">telomere-tx.com\/<\/a><\/li>\r\n<\/ul>\r\n","protected":false},"featured_media":0,"template":"","tipo_portfolio":[507],"class_list":["post-1583","portoflio_invivo","type-portoflio_invivo","status-publish","hentry","tipo_portfolio-invivoventures"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Telomere Therapeutics - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telomere Therapeutics - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Telomere Therapeutics \u00e9s una empresa spin-off del Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO) i de la Universitat Aut\u00f2noma de Barcelona (UAB). Telomere \u00e9s una empresa de ter\u00e0pia g\u00e8nica que desenvolupa tractaments modificadors de malalties per a necessitats m\u00e8diques no cobertes, sent pionera en la \u00abreparaci\u00f3 dels tel\u00f2mers\u00bb per tractar la fibrosi i altres s\u00edndromes de\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-12T09:53:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/\",\"url\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/\",\"name\":\"Telomere Therapeutics - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2020-12-12T08:16:53+00:00\",\"dateModified\":\"2023-12-12T09:53:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telomere Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Telomere Therapeutics - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/","og_locale":"ca_ES","og_type":"article","og_title":"Telomere Therapeutics - Invivo Partners","og_description":"Telomere Therapeutics \u00e9s una empresa spin-off del Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO) i de la Universitat Aut\u00f2noma de Barcelona (UAB). Telomere \u00e9s una empresa de ter\u00e0pia g\u00e8nica que desenvolupa tractaments modificadors de malalties per a necessitats m\u00e8diques no cobertes, sent pionera en la \u00abreparaci\u00f3 dels tel\u00f2mers\u00bb per tractar la fibrosi i altres s\u00edndromes de","og_url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/","og_site_name":"Invivo Partners","article_modified_time":"2023-12-12T09:53:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/","url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/","name":"Telomere Therapeutics - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2020-12-12T08:16:53+00:00","dateModified":"2023-12-12T09:53:49+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telomere-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Telomere Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo\/1583","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/portoflio_invivo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=1583"}],"wp:term":[{"taxonomy":"tipo_portfolio","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tipo_portfolio?post=1583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}